Orion Oyj (HEL:ORNBV)
Finland
· Delayed Price · Currency is EUR | Market Cap | 9.53B |
| Revenue (ttm) | 1.89B |
| Net Income (ttm) | 500.30M |
| Shares Out | 140.69M |
| EPS (ttm) | 3.56 |
| PE Ratio | 19.03 |
| Forward PE | 18.49 |
| Dividend | 1.80 (2.65%) |
| Ex-Dividend Date | Mar 25, 2026 |
| Volume | 315,642 |
| Average Volume | 209,958 |
| Open | 68.00 |
| Previous Close | 67.95 |
| Day's Range | 67.20 - 68.20 |
| 52-Week Range | 46.62 - 75.30 |
| Beta | 0.38 |
| RSI | 43.66 |
| Earnings Date | Feb 12, 2026 |
About Orion Oyj
Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. The company provides pharmaceutical products, which includes Nubeqa for the treatment of prostate cancer; Entacapone, Stalevo, Comtess, and Comtan to treat Parkinson's disease; Burana for inflammatory pain; Divina series for menopausal symptoms; Simdax for acute decompensated heart failure; Fareston for breast cancer; Trexan for rheumatoid art... [Read more]
Financial Performance
In 2025, Orion Oyj's revenue was 1.89 billion, an increase of 22.50% compared to the previous year's 1.54 billion. Earnings were 500.30 million, an increase of 51.65%.
Financial StatementsNews
Orion Oyj 2025 Q4 - Results - Earnings Call Presentation
Orion Oyj (ORINY) Q4 2025 Earnings Call Highlights: Record Growth and Strategic Developments
Orion Oyj (ORINY) Q4 2025 Earnings Call Highlights: Record Growth and Strategic Developments
Q4 2025 Orion Oyj Earnings Call Transcript
Q4 2025 Orion Oyj Earnings Call Transcript
Orion Oyj (ORINF) Q4 2025 Earnings Call Transcript
Orion Oyj (ORINF) Q4 2025 Earnings Call Transcript
Orion Oyj (ORINF) Q3 2025 Earnings Call Transcript
Orion Oyj (OTCPK:ORINF) Q3 2025 Earnings Call October 28, 2025 7:30 AM EDT Company Participants Tuukka Hirvonen - Investor Relations & Financial Communications Officer Liisa Hurme - President, CEO & C...
Orion Oyj (ORINF) Q2 2025 Earnings Call Transcript
Orion Oyj (OTCPK:ORINF) Q2 2025 Earnings Conference Call July 18, 2025 6:30 AM ET Company Participants Liisa Hurme - President, CEO & Chairman of Executive Management Board Rene Lindell - CFO & Member...
ORION Holdings Corp. (ORINF) Q1 2025 Earnings Call Transcript
ORION Holdings Corp. (OTCPK:ORINF) Q1 2025 Results Conference Call April 23, 2025 6:30 AM ET Company Participants Tuukka Hirvonen - Head of IR Liisa Hurme - CEO Rene Lindell - CFO Conference Call Part...
ORION Holdings Corp. (ORINF) Q3 2024 Earnings Call Transcript
ORION Holdings Corp. (OTCPK:ORINF) Q3 2024 Results Conference Call October 29, 2024 7:30 AM ET Company Participants Tuukka Hirvonen - Head of IR Rene Lindell - CFO Outi Vaarala - SVP, Innovative Medic...
ORION Holdings Corp. (ORINF) Q2 2024 Earnings Call Transcript
ORION Holdings Corp. (OTCPK:ORINF) Q2 2024 Results Conference Call August 8, 2024 6:30 AM ET Company Participants Tuukka Hirvonen - Investor Relations & Financial Communications Officer Liisa Hurme - ...
ORION Holdings Corp. (ORINF) Q1 2024 Earnings Call Transcript
ORION Holdings Corp. (OTCPK:ORINF) Q1 2024 Earnings Conference Call April 25, 2024 6:30 AM ET Company Participants Tuukka Hirvonen - Investor Relations & Financial Communications Officer Liisa Hurme -...
Orion Oyj (ORINF) Q4 2023 Earnings Call Transcript
Orion Oyj (ORINF) Q4 2023 Earnings Call Transcript